WTX-330 in Patients With Advanced or Metastatic Solid Tumors or Non-Hodgkin Lymphoma
Clinical trial NCT05678998 · COMPLETED
Trial details
- NCT number
- NCT05678998
- Sponsor
- Werewolf Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-06
- Primary completion
- 2024-12-23
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.